Jaffar Mohammad Khan

Jaffar Mohammad Khan

Auto-generated profile, based on publicly available information

Jaffar Mohammad Khan

Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD (T.R., J.M.K., C.G.B., A.M.S., R.J.L.).

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
JKJaffar M. Khan
Jaffar M. Khan
DDDanny Dvir
Danny Dvir
AGAdam B. Greenbaum
Adam B. Greenbaum
VBVasilis C. Babaliaros
Vasilis C. Babaliaros
TRToby Rogers
Toby Rogers
RLRobert J. Lederman
Robert J. Lederman

1 April 2017 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
VBVasilis C. Babaliaros
Vasilis C. Babaliaros
AGAdam B. Greenbaum
Adam B. Greenbaum
JKJaffar M. Khan
Jaffar M. Khan
TRToby Rogers
Toby Rogers
DWDee Dee Wang
Dee Dee Wang
RLRobert J. Lederman
Robert J. Lederman

18 May 2021 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JKJaffar M. Khan
Jaffar M. Khan
AGAdam B. Greenbaum
Adam B. Greenbaum
VBVasilis C. Babaliaros
Vasilis C. Babaliaros
DDDanny Dvir
Danny Dvir
MRMark Reisman
Mark Reisman
RLRobert J. Lederman
Robert J. Lederman
Background: Coronary artery obstruction is a rare, devastating complication of transcatheter aortic valve replacement. Transcatheter electrosurgical aortic leaflet laceration (Bioprosthetic or Native Aortic Scallop Intentional Laceration to Prevent Iatrogenic Coronary Artery Obstruction [BASILICA]) is a novel technique to prevent coronary artery obstruction. We report the 1-year outcomes of the BASILICA trial. Primary end points of 30-day success and safety have been reported previously. Methods: The BASILICA trial was a prospective, multicenter, single-arm safety and feasibility study. Subjects with severe native or bioprosthetic aortic valve disease at high or extreme risk for surgery, and high risk of coronary artery obstruction, were included. End points at 1 year included death, stroke, and myocardial infarction. Source data was independently verified and end points independently adjudicated. Results: Thirty subjects were enrolled between February 2018 and July 2018. At 30 days, BASILICA was successful in 28 subjects (93.3%), there were 3 strokes (10%), including 1 disabling stroke (3.3%), 1 death (3.3%), and 1 periprocedural myocardial infarction (3.3%). Between 30 days and 1 year, there were no additional strokes, no myocardial infarction, and 2 deaths (10% 1-year mortality). No subject needed repeat intervention for aortic valve or coronary disease. Two subjects had infective endocarditis (6.7%), but neither was isolated to the aortic valve. There were no hospital admissions for heart failure. Fourteen (46.7%) subjects required repeat hospital admission for other causes. Aortic valve gradients on echocardiography, New York Heart Association functional class, and Kansas City Cardiomyopathy Questionnaire scores improved from baseline to 30 days and were maintained at 1 year. Conclusions: In these subjects with multiple comorbidities and restrictive anatomy that underwent transcatheter aortic valve replacement, there was no late stroke, myocardial infarction, or death related to BASILICA. Mitigation of coronary obstruction remained intact at 1 year and was not related to recurrent readmission. These results are reassuring for patients and physicians who wish to avoid the long-term complications related to snorkel stenting. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03381989.

1 September 2016 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
JKJaffar M. Khan
Jaffar M. Khan
TRToby Rogers
Toby Rogers
WSWilliam H. Schenke
William H. Schenke
JMJonathan R. Mazal
Jonathan R. Mazal
AFAnthony Z. Faranesh
Anthony Z. Faranesh
RLRobert J. Lederman
Robert J. Lederman

1 December 2020 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
BFBrian J. Forrestal
Brian J. Forrestal
BCBrian C. Case
Brian C. Case
CYCharan Yerasi
Charan Yerasi
CSCorey Shea
Corey Shea
RTRebecca Torguson
Rebecca Torguson
TRToby Rogers
Toby Rogers
Background: The supra-annular leaflet position and tall stent frame of the self-expanding Evolut PRO or Evolut PRO+ transcatheter heart valves (THVs) may cause coronary occlusion during transcatheter aortic valve replacement (TAVR)-in-TAVR and present challenges for future coronary access. We sought to evaluate the risk of TAVR-in-TAVR with Evolut PRO or Evolut PRO+ THVs and the feasibility of future coronary access. Methods: The CoreValve Evolut PRO Prospective Registry (EPROMPT; NCT03423459) prospectively enrolled patients with symptomatic severe aortic stenosis to undergo TAVR using a commercially available latest generation self-expanding THV at 2 centers in the United States. Computed tomography was performed 30 days after TAVR, which we used to simulate TAVR-in-TAVR with a second Evolut PRO or Evolut PRO+ THV and evaluate for risk of coronary obstruction and feasibility of future coronary access. Results: Eighty-one patients enrolled with interpretable computed tomography are reported herein. Computed tomography simulation predicted sinus of Valsalva sequestration and resultant coronary obstruction during future TAVR-in-TAVR in up to 23% of patients. Computed tomography simulation predicted that the position of the pinned THV leaflets would hinder future coronary access in up to 78% of patients after TAVR-in-TAVR. Conclusions: Further THV design improvements and leaflet modification strategies are needed to mitigate the risk of coronary obstruction during TAVR-in-TAVR with self-expanding THVs and to facilitate future coronary access. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT03423459.

5 April 2022 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
JKJaffar M. Khan
Jaffar M. Khan
CBChristopher G. Bruce
Christopher G. Bruce
AGAdam B. Greenbaum
Adam B. Greenbaum
VBVasilis C. Babaliaros
Vasilis C. Babaliaros
AJAndrea E. Jaimes
Andrea E. Jaimes
RLRobert J. Lederman
Robert J. Lederman
Background: Left ventricular outflow tract obstruction complicates hypertrophic cardiomyopathy and transcatheter mitral valve replacement. Septal reduction therapies including surgical myectomy and alcohol septal ablation are limited by surgical morbidity or coronary anatomy and high pacemaker rates, respectively. We developed a novel transcatheter procedure, mimicking surgical myotomy, called Septal Scoring Along the Midline Endocardium (SESAME). Methods: SESAME was performed in 5 naive pigs and 5 pigs with percutaneous aortic banding–induced left ventricular hypertrophy. Fluoroscopy and intracardiac echocardiography guided the procedures. Coronary guiding catheters and guidewires were used to mechanically enter the basal interventricular septum. Imparting a tip bend to the guidewire enabled intramyocardial navigation with multiple df . The guidewire trajectory determined the geometry of SESAME myotomy. The myocardium was lacerated using transcatheter electrosurgery. Cardiac function and tissue characteristics were assessed by cardiac magnetic resonance at baseline, postprocedure, and at 7- or 30-day follow-up. Results: SESAME myotomy along the intended trajectory was achieved in all animals. The myocardium splayed after laceration, increasing left ventricular outflow tract area (753 to 854 mm 2 , P =0.008). Two naive pigs developed ventricular septal defects due to excessively deep lacerations in thin baseline septa. No hypertrophy model pig, with increased septal thickness and left ventricular mass compared with naive pigs, developed ventricular septal defects. One animal developed left axis deviation on ECG but no higher conduction block was seen in any animal. Coronary artery branches were intact on angiography with no infarction on cardiac magnetic resonance late gadolinium imaging. Cardiac magnetic resonance chamber volumes, function, flow, and global strain were preserved. No myocardial edema was evident on cardiac magnetic resonance T1 mapping. Conclusions: This preclinical study demonstrated feasibility of SESAME, a novel transcatheter myotomy to relieve left ventricular outflow tract obstruction. This percutaneous procedure using available devices, with a safe surgical precedent, is readily translatable into patients.